New 409A valuations for Indian startups with a US (Delaware) parent.New: 409A for US-parent startupsSee how it works →

Patent valuation

A patent is worth the advantage
it protects, for as long as it lasts.

Valuations of granted patents and pending applications. Grounded in claim scope, remaining life, commercial use and the cost of designing around the invention.

  • IBBI RVSecurities or Financial Assets
  • IVS 210Intangible assets
  • ICAI VSStandards followed
  • 10–15 daysSigned report
What sets the value
Claim scope
What is actually protected
Remaining life
Years of protection left
Commercial use
Revenue or savings the invention drives
Design-around
How easily a competitor avoids it

Established with inventors and counsel first.

Before any number is estimated

Overview

What is patent valuation?

Patent valuation determines the value of the exclusive rights a patent grants, for the remaining legal and economic life of the protection.

A patent is worth the advantage it protects. The valuation links the claims to the products they cover and the income or savings they make possible.

Mandates

When this valuation is needed.

  • Licensing

    In- or out-licensing

    Royalty rates supported by comparable licence evidence.

  • Transfer

    Assignment or sale

    Transfer between group entities or to a third party.

  • Financing

    IP-backed case

    Supporting an investment or financing case built on the patent.

  • Disputes

    Infringement damages

    Lost profits or a reasonable royalty.

Regulations and standards

Which regulations and standards apply.

Patents Act, 1970

Scope, term and enforceability of the rights being valued.

Ind AS 38 and Ind AS 103

Accounting for patents, including on acquisition.

Income-tax Act, 2025

Arm’s length pricing for intra-group patent transfer or licensing.

ICAI VS 302

Valuation of intangible assets.

IVS 210

International standard for intangible assets.

Provisions are confirmed against the notified text at scoping. See credentials and frameworks.

Approach

Methods, and what drives them.

MethodHow it worksWhat we test
Relief from royaltyComparable royalty rates, adjusted for scope and remaining life.The comparability of the licences relied on.
Incremental cash flowsCost savings or price premiums attributable to the invention.The link between the patent and the cash flow.
Cost approachCost to develop or design around.Used as a cross-check.

Professional insight

The weakest patent valuations treat the patent and the product as the same thing. They rarely are.

The report

What the report contains.

  1. 01Description and legal status of the asset
  2. 02Ownership, rights and encumbrances
  3. 03Economic life and remaining useful life
  4. 04Method applied, with inputs and sources
  5. 05Sensitivity of value to key inputs
  6. 06Concluded value for the stated purpose

Engagement

How a mandate runs.

  1. Day 0–1ScopingPurpose, valuation date, basis of value and deliverable confirmed in an engagement letter, after an independence check.
  2. Days 1–3InformationRegistration documents, licences, revenue attributable to the asset, then sessions with the business and technical teams.
  3. Days 5–7Indicative viewApproaches applied and assumptions tested. The indicative view is discussed with you before the report is finalised.
  4. Days 10–15Signed reportSigned by the Registered Valuer, who also answers later questions from reviewers.

Why Fintellectual

Why appoint Fintellectual Valuation.

  • Single point of responsibility

    The valuer who signs

    CA Devansh Shah scopes, leads and signs every mandate. You are never passed between teams.

  • Registered for the purpose

    IBBI RV and Chartered Accountant

    Registered Valuer for Securities or Financial Assets, and a member of ICAI. Numbers are stated on every report.

  • Independent

    Valuation only

    No audit, no investment role and no incentive to reach a number other than the one the evidence supports.

  • Built for scrutiny

    For the reader who tests it

    Valuation that reads the claims and the remaining term, not just the business plan.

About CA Devansh Shah →

Questions

Asked before most instructions.

Can a pending application be valued?

Yes, with the probability and likely scope of grant reflected in the analysis.

Contact

Discuss the mandate with the valuer who will lead it.

Share the purpose, the parties and the date that matters. You will hear back from CA Devansh Shah within one business day.

Discuss a mandate Talk to a valuer